Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis

Clinical trial NCT01969838 · COMPLETED

Trial details

NCT number: NCT01969838
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis

Start date: 2013-12-06
Primary completion: 2016-09-12
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.